Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 745

Results For "US"

8040 News Found

Temasek to buy a stake in Integrace
Startup | October 05, 2021

Temasek to buy a stake in Integrace

The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition


DentalMonitoring launches ScanBox, an AI-powered orthodontic care device
Medical Device | October 05, 2021

DentalMonitoring launches ScanBox, an AI-powered orthodontic care device

DentalMonitoring, the company that pioneered artificial intelligence in dental and orthodontic care, has announced the launch of the ScanBox


Mawi DNA announce partnership with FUJIFILM
Medical Device | October 05, 2021

Mawi DNA announce partnership with FUJIFILM

FUJIFILM will distribute iSWAB bio sampling technologies in Japan


Health ministry’s eSanjeevani completes 1.3 crore consultations
Public Health | October 05, 2021

Health ministry’s eSanjeevani completes 1.3 crore consultations

More than 90,000 patients utilise the services daily


ResMed acquires home sleep testing company Ectosense
Startup | October 05, 2021

ResMed acquires home sleep testing company Ectosense

Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test


Moderna Science Centre coming up in Cambridge, MA
Biotech | October 04, 2021

Moderna Science Centre coming up in Cambridge, MA

The 462,000 square foot state-of-the-art building targeting LEED Zero certification and is designed to be the most sustainable commercial lab building in Cambridge


Max Healthcare to construct two 500-bed hospitals in Gurugram
Hospitals | October 04, 2021

Max Healthcare to construct two 500-bed hospitals in Gurugram

The two plots are located in the heart of Gurugram close to Sectors 53 on the Golf Course Road and Sector 56 just minutes away from the other location


Pfizer transfers certain medicines to Mylan as part of an agreement
News | October 04, 2021

Pfizer transfers certain medicines to Mylan as part of an agreement

The consideration for the medicines in India is valued at Rs 180.48 crore


Thermo Fisher opens biologics site in Lengnau, Switzerland
News | October 04, 2021

Thermo Fisher opens biologics site in Lengnau, Switzerland

The state-of-the-art facility provides a pathway from development to large-scale biologics production


Lilly to transfer rights of two diabetes drugs to Cipla in India
Drug Approval | October 04, 2021

Lilly to transfer rights of two diabetes drugs to Cipla in India

Lilly will continue to maintain its existing operating model for the remaining portfolio of products